New research progress on 57196-62-0 in 2021. Application of 57196-62-0, Catalysts function by providing an alternate reaction mechanism that has a lower activation energy than would be found in the absence of the catalyst. In some cases, the catalyzed mechanism may include additional steps.In a article, 57196-62-0, molcular formula is C10H14ClNO, introducing its new discovery.
Sulfonyl derivatives represented by the following general formula (I): Q1-Q2-T1-Q3-SO2-QAand drugs containing the same (wherein Q1is an optionally substituted, saturated or unsaturated, five- or six-membered cyclic hydrocarbon group, a five- or six-membered heterocyclic group, or the like; Q2is a single band, oxygen, sulfur, C1-C6alkylene or the like; QAis optionally substituted arylalkenyl, heteroarylalkenyl or the like; and T1is carbonyl or the like). These compounds have potent FXa-inhibitory effects and promptly exert satisfactory and persistent antithrombotic effects through oral administration, thus being useful as anticoagulant agents little accompanied with side effects.
A reaction mechanism is the microscopic path by which reactants are transformed into products. Each step is an elementary reaction. In my other articles, you can also check out more blogs about 57196-62-0
Reference：
Tetrahydroisoquinoline – Wikipedia,
1,2,3,4-Tetrahydroisoquinoline | C9H11N – PubChem